<VariationArchive RecordType="classified" VariationID="818204" VariationName="NM_006097.5(MYL9):c.184+2_184+10del" VariationType="Deletion" Accession="VCV000818204" Version="4" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-08-06" DateCreated="2020-03-16" MostRecentSubmission="2021-06-19">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="806410" VariationID="818204">
      <GeneList>
        <Gene Symbol="DLGAP4-AS1" FullName="DLGAP4 antisense RNA 1" GeneID="101926987" HGNC_ID="HGNC:51223" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>20q11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="36507702" stop="36573275" display_start="36507702" display_stop="36573275" Strand="-" />
          </Location>
        </Gene>
        <Gene Symbol="MYL9" FullName="myosin light chain 9" GeneID="10398" HGNC_ID="HGNC:15754" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>20q11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="36541519" stop="36551447" display_start="36541519" display_stop="36551447" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="35169886" stop="35178225" display_start="35169886" display_stop="35178225" Strand="+" />
          </Location>
          <OMIM>609905</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_006097.5(MYL9):c.184+2_184+10del</Name>
      <CanonicalSPDI>NC_000020.11:36545063:GCTGGGTGAGCTGGG:GCTGGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>20q11.23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="36545064" stop="36545072" display_start="36545064" display_stop="36545072" variantLength="9" positionVCF="36545063" referenceAlleleVCF="CGCTGGGTGA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="35173467" stop="35173475" display_start="35173467" display_stop="35173475" variantLength="9" positionVCF="35173466" referenceAlleleVCF="CGCTGGGTGA" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.35173473_35173481del" Assembly="GRCh37">
            <Expression>NC_000020.10:g.35173473_35173481del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.36545070_36545078del" Assembly="GRCh38">
            <Expression>NC_000020.11:g.36545070_36545078del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006097.5" sequenceAccession="NM_006097" sequenceVersion="5" change="c.184+2_184+10del" MANESelect="true">
            <Expression>NM_006097.5:c.184+2_184+10del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181526.3" sequenceAccession="NM_181526" sequenceVersion="3" change="c.184+2_184+10del">
            <Expression>NM_181526.3:c.184+2_184+10del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="609905.0001" DB="OMIM" />
        <XRef Type="rs" ID="1569529545" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006097.5(MYL9):c.184+2_184+10del AND Visceral myopathy 1" Accession="RCV001009609" Version="2">
        <ClassifiedConditionList TraitSetID="13780">
          <ClassifiedCondition DB="MedGen" ID="C5542197">Visceral myopathy 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-02-26" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006097.5(MYL9):c.184+2_184+10del AND Megacystis-microcolon-intestinal hypoperistalsis syndrome 4" Accession="RCV001523898" Version="2">
        <ClassifiedConditionList TraitSetID="67182">
          <ClassifiedCondition DB="MedGen" ID="C5543519">Megacystis-microcolon-intestinal hypoperistalsis syndrome 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-06-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-02-26" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-03-16" MostRecentSubmission="2021-06-19">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Uncertain significance</Description>
        <Citation Type="general">
          <ID Source="PubMed">21293372</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33031641</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="13780" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2739" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Pseudoobstruction idiopathic intestinal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Megaduodenum and/or megacystis</ElementValue>
                <XRef ID="Megaduodenum+and-or+megacystis/4557" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Infantile visceral myopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Visceral myopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Visceral myopathy 1</ElementValue>
                <XRef ID="MONDO:0020754" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">VSCM1</ElementValue>
                <XRef Type="MIM" ID="155310" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">ACTG2-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">ACTG2 visceral myopathy is a disorder of smooth muscle dysfunction of the bladder and gastrointestinal system with phenotypic spectrum that ranges from mild to severe. Bladder involvement can range from neonatal megacystis and megaureter (with its most extreme form of prune belly syndrome) at the more severe end, to recurrent urinary tract infections and bladder dysfunction at the milder end. Intestinal involvement can range from malrotation, neonatal manifestations of microcolon, megacystis microcolon intestinal hypoperistalsis syndrome, and chronic intestinal pseudoobstruction (CIPO) in neonates at the more severe end to intermittent abdominal distention and functional intestinal obstruction at the milder end. Affected infants (with or without evidence of intestinal malrotation) often present with feeding intolerance and findings of non-mechanical bowel obstruction that persist after successful surgical correction of malrotation. Individuals who develop manifestations of CIPO in later childhood or adulthood often experience episodic waxing and waning of bowel motility. They may undergo frequent abdominal surgeries (perhaps related to malrotation or adhesions causing mechanical obstruction) resulting in resection of dilated segments of bowel, often becoming dependent on total parenteral nutrition (TPN).</Attribute>
                <XRef ID="NBK299311" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">26072522</ID>
                <ID Source="BookShelf">NBK299311</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31070878</ID>
                <ID Source="BookShelf">NBK540960</ID>
              </Citation>
              <XRef ID="2604" DB="Orphanet" />
              <XRef ID="C5542197" DB="MedGen" />
              <XRef ID="MONDO:0020754" DB="MONDO" />
              <XRef Type="MIM" ID="155310" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="67182" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="56222" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Megacystis-microcolon-intestinal hypoperistalsis syndrome 4</ElementValue>
                <XRef ID="MONDO:0030296" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MMIHS4</ElementValue>
                <XRef Type="MIM" ID="619365" DB="OMIM" />
              </Symbol>
              <XRef ID="C5543519" DB="MedGen" />
              <XRef ID="MONDO:0030296" DB="MONDO" />
              <XRef Type="MIM" ID="619365" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2307694" SubmissionDate="2020-03-09" DateLastUpdated="2020-03-16" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="SUB7037592" submittedAssembly="GRCh37" title="SUB7037592" />
        <ClinVarAccession Accession="SCV001164303" DateUpdated="2020-03-16" DateCreated="2020-03-16" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="clinic" OrgAbbreviation="FLGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-02-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>This intronic variant, NM_006097.4:c.184+2_184+10del, was identified in trans with a heterozygous deletion of exon 4 in an individual with a clinical diagnosis of MMIH syndrome: bilateral hydronephrosis, megacystis, congenital bilateral mydriasis, lack of urinary bladder peristalsis, and intestinal pseudo-obstruction. This intronic variant alters the highly conserved splice donor site for exon 2 of this transcript and is predicted by five splice site prediction tools queried to abolish canonical splice donor activity. This variant is expected to result in altered function of the MYL9 gene product as a result of aberrant splicing. This variant has been observed at a frequency of less than 0.01% (2/245706 alleles) across the entire Broad data set (individuals without severe childhood onset disease).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0007932" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0004388" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000021" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0004389" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000126" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002506" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001655" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0006094" />
              </Trait>
            </TraitSet>
            <Comment>Seen in trans with exon 4 deletion in MYL9</Comment>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYL9">
              <Name>myosin light chain 9</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_006097.4:intron 2</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_181526.2:c.184+2_184+10del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006097.4:c.184+2_184+10del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA2241" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7037592</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3410895" SubmissionDate="2021-06-16" DateLastUpdated="2021-06-19" DateCreated="2021-06-19">
        <ClinVarSubmissionID localKey="609905.0001_MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 4 (1 patient)" title="MYL9, 9-BP DEL, IVS2, c.184+2_184+10del_MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 4 (1 patient)" />
        <ClinVarAccession Accession="SCV001733632" DateUpdated="2021-06-19" DateCreated="2021-06-19" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 2-year-old girl with megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS4; 619365), Kandler et al. (2020) identified compound heterozygosity for 2 mutations in the MYL9 gene: a 9-bp deletion in intron 2 (c.184+2_184+10del, NM_006097.5) that removes the canonical splice donor site at exon 2, and a deletion that included all of exon 4 and the complete 3-prime UTR. The unaffected parents were each heterozygous for one of the mutations. The authors stated that the splicing variant was found in heterozygous state in 2 of 125,462 individuals in gnomAD, for an estimated allele frequency of 1/62,371, and that a similar deletion including exon 4 was reported in heterozygous state in 2 of 2,504 individuals by Mills et al. (2011), for an estimated allele frequency of 1/1,250.</Attribute>
              <Citation>
                <ID Source="PubMed">33031641</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">21293372</ID>
              </Citation>
              <XRef DB="OMIM" ID="619365" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYL9" />
          </GeneList>
          <Name>MYL9, 9-BP DEL, IVS2, c.184+2_184+10del</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">9-BP DEL, IVS2, c.184+2_184+10del</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="609905.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 4 (1 patient)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2307694" TraitType="Finding" MappingType="XRef" MappingValue="HP:0006094" MappingRef="HP">
        <MedGen CUI="C0574974" Name="Finger joint hypermobility" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2307694" TraitType="Finding" MappingType="XRef" MappingValue="HP:0004389" MappingRef="HP">
        <MedGen CUI="C0021847" Name="Intestinal pseudo-obstruction" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2307694" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA2241" MappingRef="Orphanet">
        <MedGen CUI="C1608393" Name="Megacystis, microcolon, hypoperistalsis syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2307694" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000021" MappingRef="HP">
        <MedGen CUI="C1855311" Name="Megacystis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2307694" TraitType="Finding" MappingType="XRef" MappingValue="HP:0004388" MappingRef="HP">
        <MedGen CUI="C0266200" Name="Microcolon" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2307694" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002506" MappingRef="HP">
        <MedGen CUI="C0598275" Name="Diffuse cerebral atrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2307694" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001655" MappingRef="HP">
        <MedGen CUI="C0016522" Name="Patent foramen ovale" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2307694" TraitType="Finding" MappingType="XRef" MappingValue="HP:0007932" MappingRef="HP">
        <MedGen CUI="C4024770" Name="Bilateral congenital mydriasis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2307694" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000126" MappingRef="HP">
        <MedGen CUI="C0020295" Name="Hydronephrosis" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

